These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 24117205)

  • 21. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
    Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Poorly differentiated carcinoma of the thyroid--immunohistochemical evaluation of p53 and p27 protein expression].
    Wierzchowski W; Szybiński P; Nowak W; Nowak K; Szybiński Z; Buziak-Bereza M; Stachura J
    Wiad Lek; 2001; 54 Suppl 1():79-87. PubMed ID: 12182066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
    Zeng Q; Chen G; Vlantis A; Tse G; van Hasselt C
    J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression in poorly differentiated papillary thyroid carcinomas.
    Fluge Ø; Bruland O; Akslen LA; Lillehaug JR; Varhaug JE
    Thyroid; 2006 Feb; 16(2):161-75. PubMed ID: 16676402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the ring ligase PRAJA2 in thyroid cancer.
    Cantara S; D'Angeli F; Toti P; Lignitto L; Castagna MG; Capuano S; Prabhakar BS; Feliciello A; Pacini F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4253-9. PubMed ID: 22948757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide appraisal of thyroid cancer progression.
    Wreesmann VB; Ghossein RA; Patel SG; Harris CP; Schnaser EA; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
    Am J Pathol; 2002 Nov; 161(5):1549-56. PubMed ID: 12414503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?
    Dettmer M; Schmitt A; Steinert H; Haldemann A; Meili A; Moch H; Komminoth P; Perren A
    Am J Surg Pathol; 2011 Dec; 35(12):1866-72. PubMed ID: 21989341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
    Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
    Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
    Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
    Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma.
    Wiseman SM; Griffith OL; Deen S; Rajput A; Masoudi H; Gilks B; Goldstein L; Gown A; Jones SJ
    Arch Surg; 2007 Aug; 142(8):717-27; discussion 727-9. PubMed ID: 17709725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas.
    Sakamoto A; Kasai N; Sugano H
    Cancer; 1983 Nov; 52(10):1849-55. PubMed ID: 6313176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.
    Ferraro A; Schepis F; Leone V; Federico A; Borbone E; Pallante P; Berlingieri MT; Chiappetta G; Monaco M; Palmieri D; Chiariotti L; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2834-43. PubMed ID: 23666966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
    Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas.
    Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
    Anticancer Res; 2003; 23(3B):2349-53. PubMed ID: 12894514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.
    Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL
    Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.